Although the development of MDM4 inhibitors lagged behind that of MDM2 inhibitors, it has been increasingly promoted in recent years, in part by research showing that the persistent expression of MDM4 in cancer cells counteracted the cytotoxic effects of MDM2 inhibition [7,10,24]. This evidence concerns the gene MDM2 and cancer.